Science should have no borders

HHIV7311 copy.jpg

Tehran (ISNA) - Scientists had a major role to play in addressing the challenges to a sustainable future, Assistant professor in Oncology and Hematology at the University of Modena emphasized.

“By joint scientific works, we combine our resources and expertise to raise awareness, build capacity, and initiate lasting solutions which are necessary for every society,” Massimo Dominici told in an exclusive interview to ISNA.

“The 2nd International conference of Stem cells and Regenerative Medicine which was a good combination of basic research with specific attention on how to translate these basic research to clinical scenario, was a good opportunity for doing this which I think is very relevant for this field and I am so pleased to see this development in Iran,” he said.

“I was positively surprised to find out that the level of this conference was not only high but the students were very motivated and advanced in this field so I think Iran invested in the future of Stem Cells,” Dominici added.

Dominici continued they looked forward to exploring future collaboration and mutual exchanges of ideas with Iran Universities and research centers.  

He suggested the students to constantly ask themselves the right questions because in this way they can find the right answer.

Dr. Massimo Dominici is currently working as assistant professor of Medical Oncology and head of the Laboratory of Cellular Therapies at University/Hospital of Modena. He was a Postdoctoral research associate at St Jude Children's Hospital, USA and also worked as associate professor of Medical Oncology.

 He received many research grants and awards. He authored books, book chapters and about 80 articles, and has six deposited patents.

Dr. Massimo Dominici’s research interest includes stem cell biology and its translational applications in oncology-hematology and regenerative medicine, focusing on hematopoietic and mesenchymal stromal/stem cells (MSC).

 The actual projects are aimed to clarify the interactions between MSC and marrow cells to improve bone and marrow regeneration, to develop cancer gene therapy approaches based on immune cells and MSC and to develop tools to increase MSC performance and safety for clinical uses.

End Item


You are replying to: .